CapsoVision, Inc. (CV)

CapsoVision will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet
Chart not available yet
Data will show when the stock starts trading.
Market Cap n/a
Revenue (ttm) 12.04M
Net Income (ttm) -21.07M
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range n/a
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About CV

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies that are deployed in our capsule endoscopy solutions to identify abnormalities of the gastrointestinal tract for diagnostic and screening purposes. We developed our first capsule endoscope system, currently comprising the CapsoCam Plus single-use capsule and the CapsoCloud and CapsoView software, to panoramically visualize the small-bowel mucosa to investigate abnormalities such as obscure GI bleeding and Crohn’s ... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2005
Employees 90
Stock Exchange NASDAQ
Ticker Symbol CV
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Medical device maker CapsoVision files for a $30 million IPO

CapsoVision, which makes a capsule endoscope system for diagnostic and screening applications, filed on Friday with the SEC to raise up to $30 million in an initial public offering.

2 days ago - Renaissance Capital

CapsoVision IPO Registration Document (S-1)

CapsoVision has filed to go public with an IPO on the NASDAQ.

2 days ago - SEC